Evelo Biosciences

Closed

Cambridge, United States · Founded 2015

Employees
51–200
Founded
2015
Business Model
B2B

About

Evelo Biosciences is a clinical-stage biotechnology company developing orally delivered medicines that act on SINTAX, the small intestinal axis, to treat a range of inflammatory and immune-mediated diseases. Headquartered in Cambridge, Massachusetts, Evelo's monoclonal microbial product candidates are designed to computationally identify single strains of gut bacteria intended to have a systemic effect on the immune system without being absorbed into the bloodstream.

Summary

Evelo Biosciences is a Biotech company based in Cambridge, United States, founded in 2015. Investors include Horizon Technology Finance and K2 HealthVentures.

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Debt FinancingLoan AgreementDec 2022
$45.0M

Sign up to see all 2 events

Funding, valuations, and company events, with amounts and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Evelo Biosciences on Indexed.vc
<a href="https://indexed.vc/companies/evelo-biosciences"><img src="https://indexed.vc/api/badge/company/evelo-biosciences" alt="Evelo Biosciences on Indexed.vc" width="260" height="76" /></a>